Updates are available Correction dated 2020-11-20
Click to view Correction: https://doi.org/10.1186/s12864-020-07039-2
-
Authors
Breton, Camilo
Clark, Peter M.
Wang, Lili
Greig, Jenny A.
Wilson, James M. http://orcid.org/0000-0002-9630-3131
-
Funding
Funding for this research was provided by:
Precision Biosciences (N/A)
Perelman School of Medicine, University of Pennsylvania (N/A)
- License Information
-
More Information
Article History
Received: 17 December 2019
Accepted: 5 March 2020
First Online: 17 March 2020
Change Date: 20 November 2020
Change Type: Correction
Change Details: An amendment to this paper has been published and can be accessed via the original article.
Ethics approval and consent to participate
: All animal procedures were performed in accordance with protocols approved by the Institutional Animal Care and Use Committee of the University of Pennsylvania. No additional studies in rhesus macaques were performed, only DNA samples from previously published studies [CitationRef removed] [CitationRef removed] were used here. All animal procedures were performed in accordance with protocols approved by the Institutional Animal Care and Use Committee (IACUC) of the University of Pennsylvania. Mouse studies were performed under IACUC protocol 803270 and mice were obtained from The Jackson Laboratory (Bar Harbor, ME). “Consent to participate” is not applicable as this study did not involve human participants.
: Not applicable as this study did not involve human participants.
: J.M. Wilson is a paid advisor to and holds equity in Scout Bio and Passage Bio; he holds.equity in Surmount Bio; he also has a sponsored research agreement with Ultragenyx,Biogen, Janssen, Precision Biosciences, Moderna Inc., Scout Bio, Passage.Bio, Amicus Therapeutics, and Surmount Bio which are licensees of Penn technology.JMW is an inventor on patents that have been licensed to various biopharmaceutical.companies and for which he may receive payments.
